Cengild Medical Berhad (0243) - Total Assets
Based on the latest financial reports, Cengild Medical Berhad (0243) holds total assets worth RM217.91 Million MYR (≈ $54.71 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Cengild Medical Berhad - Total Assets Trend (2020–2025)
This chart illustrates how Cengild Medical Berhad's total assets have evolved over time, based on quarterly financial data. Also see market value of Cengild Medical Berhad for the company's overall valuation and market capitalisation.
Cengild Medical Berhad - Asset Composition Analysis
Current Asset Composition (June 2025)
Cengild Medical Berhad's total assets of RM217.91 Million consist of 54.5% current assets and 45.5% non-current assets. Review 0243 liabilities breakdown to assess the company's total debt and financial obligations.
| Asset Category | Amount (MYR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | RM0.00 | 6.5% |
| Accounts Receivable | RM8.48 Million | 4.7% |
| Inventory | RM2.05 Million | 1.1% |
| Property, Plant & Equipment | RM0.00 | 0.0% |
| Intangible Assets | RM0.00 | 0.0% |
| Goodwill | RM0.00 | 0.0% |
Asset Composition Trend (2020–2025)
This chart illustrates how Cengild Medical Berhad's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Cengild Medical Berhad stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Cengild Medical Berhad's current assets represent 54.5% of total assets in 2025, an increase from 22.5% in 2020.
- Cash Position: Cash and equivalents constituted 6.5% of total assets in 2025, down from 11.8% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2020.
- Asset Diversification: The largest asset category is accounts receivable at 4.7% of total assets.
Cengild Medical Berhad Competitors by Total Assets
Key competitors of Cengild Medical Berhad based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Ramsay Health Care Ltd
AU:RHC
|
Australia | AU$21.70 Billion |
|
Surgery Partners Inc
NASDAQ:SGRY
|
USA | $7.95 Billion |
|
Chularat Hospital Public Company Limited
BK:CHG
|
Thailand | ฿10.15 Billion |
|
Sarana Meditama Metropolitan
JK:SAME
|
Indonesia | Rp5.71 Trillion |
|
Principal Capital Public Company Limited
BK:PRINC
|
Thailand | ฿16.51 Billion |
|
Bait Bakfar Ltd
TA:BKFR
|
Israel | ILA2.25 Billion |
|
Regis Healthcare Ltd
AU:REG
|
Australia | AU$2.11 Billion |
|
Oceania Healthcare Ltd
AU:OCA
|
Australia | AU$3.01 Billion |
Cengild Medical Berhad - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.93 | 4.44 | 7.87 |
| Quick Ratio | 3.81 | 4.35 | 7.74 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | RM50.26 Million | RM80.79 Million | RM82.49 Million |
Cengild Medical Berhad - Advanced Valuation Insights
This section examines the relationship between Cengild Medical Berhad's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.40 |
| Latest Market Cap to Assets Ratio | 0.23 |
| Asset Growth Rate (YoY) | 36.3% |
| Total Assets | RM180.49 Million |
| Market Capitalization | $40.78 Million USD |
Valuation Analysis
Below Book Valuation: The market values Cengild Medical Berhad's assets below their book value (0.23x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Cengild Medical Berhad's assets grew by 36.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Cengild Medical Berhad (2020–2025)
The table below shows the annual total assets of Cengild Medical Berhad from 2020 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | RM180.49 Million ≈ $45.31 Million |
+36.28% |
| 2024-06-30 | RM132.44 Million ≈ $33.25 Million |
+0.54% |
| 2023-06-30 | RM131.73 Million ≈ $33.07 Million |
+10.19% |
| 2022-06-30 | RM119.54 Million ≈ $30.01 Million |
+160.01% |
| 2021-06-30 | RM45.98 Million ≈ $11.54 Million |
-2.37% |
| 2020-06-30 | RM47.09 Million ≈ $11.82 Million |
-- |
About Cengild Medical Berhad
Cengild Medical Berhad, an investment holding company, operates a medical center in Malaysia. The company offers various care and treatment consultant services for gastrointestinal and liver diseases, morbid obesity, and oncology and urological conditions; general cardiology and gynecology assessment; gastroenterology and hepatology; anesthesiology, general surgery, internal medicine, and radiolo… Read more